Connor, Clark & Lunn Investment Management Ltd. Ironwood Pharmaceuticals Inc Transaction History
Connor, Clark & Lunn Investment Management Ltd.
- $18.8 Billion
- Q3 2024
A detailed history of Connor, Clark & Lunn Investment Management Ltd. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Connor, Clark & Lunn Investment Management Ltd. holds 126,289 shares of IRWD stock, worth $531,676. This represents 0.0% of its overall portfolio holdings.
Number of Shares
126,289
Previous 50,372
150.71%
Holding current value
$531,676
Previous $328,000
58.23%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding IRWD
# of Institutions
238Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$96.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$92.8 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$69 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.3MShares$47.5 Million0.11% of portfolio
-
State Street Corp Boston, MA9.92MShares$41.8 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $645M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...